These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18493251)

  • 1. Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex.
    Geldof M; Freijer JI; van Beijsterveldt L; Langlois X; Danhof M
    Br J Pharmacol; 2008 Jul; 154(6):1369-78. PubMed ID: 18493251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.
    Geldof M; Freijer J; van Beijsterveldt L; Danhof M
    Pharm Res; 2008 Apr; 25(4):792-804. PubMed ID: 17710515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex.
    Geldof M; Freijer JI; Peletier LA; van Beijsterveldt L; Danhof M
    Eur J Pharm Sci; 2008 Mar; 33(3):217-29. PubMed ID: 18207708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior.
    Geldof M; Freijer J; van Beijsterveldt L; Vermote PC; Megens AA; Danhof M
    Eur J Pharm Sci; 2007 Nov; 32(3):200-8. PubMed ID: 17825539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.
    Bourdet DL; Tsuruda PR; Obedencio GP; Smith JA
    J Pharmacol Exp Ther; 2012 Apr; 341(1):137-45. PubMed ID: 22235148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine.
    Benmansour S; Piotrowski JP; Altamirano AV; Frazer A
    Neuropsychopharmacology; 2009 Feb; 34(3):555-64. PubMed ID: 18322468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
    Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies.
    Geldof M; Freijer J; van Beijsterveldt L; Timmerman P; Ahnaou A; Drinkenburg WH; Danhof M
    Eur J Pharm Sci; 2007 Jan; 30(1):45-55. PubMed ID: 17134886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.
    Bosker FJ; van Esseveldt KE; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 1995 Feb; 117(3):358-63. PubMed ID: 7770611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
    Kreilgaard M; Smith DG; Brennum LT; Sánchez C
    Br J Pharmacol; 2008 Sep; 155(2):276-84. PubMed ID: 18552871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons.
    Montañez S; Daws LC; Gould GG; Frazer A
    J Neurochem; 2003 Nov; 87(4):861-7. PubMed ID: 14622117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
    Nakada S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):51-60. PubMed ID: 11062862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.
    Miura H; Qiao H; Kitagami T; Ohta T; Ozaki N
    Psychopharmacology (Berl); 2005 Jan; 177(3):307-14. PubMed ID: 15290002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [(11)C](+)McN5652 and [(11)C](-)McN5652 in conscious monkeys.
    Kakiuchi T; Tsukada H; Fukumoto D; Nishiyama S
    Synapse; 2001 Jun; 40(3):170-9. PubMed ID: 11304754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
    Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
    Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.
    Capello CF; Bourke CH; Ritchie JC; Stowe ZN; Newport DJ; Nemeroff A; Owens MJ
    J Pharmacol Exp Ther; 2011 Oct; 339(1):275-85. PubMed ID: 21775476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single and repeated administration of fluvoxamine on noradrenaline release in rat brain.
    Shachar D; Klein E; Tabak A; Finberg JP
    Eur J Pharmacol; 1997 Aug; 332(3):237-43. PubMed ID: 9300255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations.
    Bundgaard C; Sveigaard C; Brennum LT; Stensbøl TB
    Xenobiotica; 2012 Mar; 42(3):256-65. PubMed ID: 22017605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
    Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.